Bovilis IBR marker live, liofilizatas ir skiediklis suspensijai ruošti galvijams
Bovilis IBR marker live, liofilizatas ir skiediklis suspensijai ruošti galvijams
Authorised
- Bovine herpesvirus 1, strain GK/D gE gene-deleted, Live
Product identification
Medicine name:
Bovilis IBR marker live, liofilizatas ir skiediklis suspensijai ruošti galvijams
Active substance:
- Bovine herpesvirus 1, strain GK/D gE gene-deleted, Live
Target species:
-
Cattle
Route of administration:
-
Nasal use
Product details
Active substance and strength:
-
Bovine herpesvirus 1, strain GK/D gE gene-deleted, Live19952600.00tissue culture infective dose 501.00Dose
Pharmaceutical form:
-
Nasal drops, lyophilisate and solvent for suspension
Withdrawal period by route of administration:
-
Nasal use
- Cattle
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- SFVS
Authorisation number:
- LT/2/03/1554/001-010
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 12/01/2023
How useful was this page?: